Search Results - "Cai, Chenghang" :: K.UTB vyhledávací portál

Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial

by Ji, Linong, Gao, Leili, Jiang, Hongwei, Yang, Jing, Yu, Lei, Wen, Jie, Cai, Chenghang, Deng, Huan, Feng, Liqi, Song, Baili, Ma, Qingyang, Qian, Lei
Published in EClinicalMedicine (01.12.2022)

Get full text

Journal Article

Loading…

Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study

by He, Jinjie, Du, Weijuan, Yang, Haijing, Wang, Jingjing, Cai, Chenghang, Ma, Qingyang, Li, Nanyang, Yu, Jicheng, Wu, Xiaojie, Wu, Jufang, Chen, Yuancheng, Cao, Guoying, Zhang, Jing
Published in Expert opinion on investigational drugs (03.07.2023)

Get more information

Journal Article

Loading…

ODP014 Safety and Efficacy of IBI362 (LY3305677) 9 mg and 10 mg in Chinese Adults with Overweight or Obesity

by Ji, Linong, Jiang, Hongwei, Yang, Jing, Yu, Lei, Cai, Chenghang, Liu, Meng, Deng, Huan, Feng, Liqi, Qian, Lei
Published in Journal of the Endocrine Society (01.11.2022)

Get full text

Journal Article